hidden
Over 10 years experience of Traceability Solutions
By Pharmatrax Author
Category: News
No Comments
Recent trends in specialty pharma business model
1. Defining specialty pharma “What is specialty pharma?” many people question me. Is it in-licensing specialists? Niche marketers? Drug delivery firms? Will generic drug manufacturers be included? How…
By Pharmatrax Author
Category: News
No Comments
Pharma 4.0: analysis on core competence and digital levelling implementation in pharmaceutical industry in Indonesia
1. Introduction Implementing Industry 4.0 through a transition from conventional manufacturing is challenging, especially for emerging economies (Samaranayake et al., 2018). Manufacturing companies need to recognize the Industry 4.0…
By Pharmatrax Author
Category: Technoloy
No Comments
The changing model of big pharma: impact of key trends
Introduction Big pharma has seen a significant change in operating model and footprint over the past couple of decades. Several studies have reviewed the industry’s…
By Pharmatrax Author
Category: Technoloy
No Comments
Blockchain: A new safeguard for agri-foods
1. Introduction Blockchain technology, also referred to as distributed ledger technology, is a type of public bookkeeping protocol executed by a network of computing systems. The…
By Pharmatrax Author
Category: News
No Comments
The Top 5 Healthcare Trends In 2023
Artificial Intelligence in Healthcare The market for Artificial intelligence (AI) – specifically, machine learning (ML) tools in healthcare is forecast to top $20 million in 2023. Various…
By Pharmatrax Author
Category: News
No Comments
Pharmaceutical Traceability Market: Production, Revenue, Price and Gross Margin Analysis with Forecasts to 2030! Optel Ltd., The Healthcare Distribution Alliance (HDA) Inc., Bureau Veritas, Adents, Logista Pharma
“Pharmaceutical Traceability Market” research report 2022-2030 provides a meticulous assessment of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and…
By Pharmatrax Author
No Comments
Innovation and R&D key to accelerating the growth of Indian pharma
The biotechnology and pharmaceutical sectors have showcased resilience and grit in the face of the pandemic, continuously evolving and innovating for better outcomes. The industry…
By Pharmatrax Author
Category: News
No Comments
Pharma industry says taking steps to check misuse of codeine drugs
The fate of some marquee brands is uncertain as the government phases out codeine-based cough formulations and a handful of fixed-dose combination (FDC) drugs. Some of these…
By Pharmatrax Author
Category: News
No Comments
Securing Europe’s Critical Entities from Cyber Attacks
On 28 October 2021, the Parliament of the European Union (EU) adopted the revised Network and Information Security (NIS) Directive, commonly referred to as NIS-2,…
By Pharmatrax Author
Category: News
No Comments
Adopting Smart Development Strategies
According to research, post-pandemic R&D growth is healthy in the pharma industry with the number of drugs in the R&D pipeline now exceeding 20,000 in…
